Search alternatives:
significantly affected » significantly associated (Expand Search), significantly reduced (Expand Search), significant effect (Expand Search)
affected decrease » affected areas (Expand Search), effects decreased (Expand Search)
significantly affected » significantly associated (Expand Search), significantly reduced (Expand Search), significant effect (Expand Search)
affected decrease » affected areas (Expand Search), effects decreased (Expand Search)
-
21
-
22
HFD decreases intermediate-term memory.
Published 2025“…<p>(A) The survival rate of 10d <i>Canton-S</i> fed with ND or HFD was observed for 7 days. There was no significant decline in the survival rate in flies fed with HFD compared with ND (n = 10 vials, containing 20 flies at each time point). …”
-
23
-
24
Forest maps affecting lactation outcomes.
Published 2024“…</p><p>Results</p><p>We found that numerical rating scale(NRS) score and incidence of breast fistula in group A were significantly lower than other, the continuous decrease of postoperative drainage in group A was higher than other, there were significant differences among groups (p<0.001). …”
-
25
-
26
-
27
-
28
-
29
-
30
-
31
Downregulation of <i>TcPiezo1</i> expression decreases Ca<sup>2+</sup> entry in <i>T. cruzi.</i>
Published 2025“…(B) Downregulation of <i>TcPiezo1</i> expression showed a significant decrease of intracellular Ca<sup>2+</sup> (+Tet). …”
-
32
Vertebral cancellous tissueμCT parameters are not significantly affected by aging from 16 to 21 weeks, housing type, or microgravity.
Published 2025“…Nonsignificant trends implicate an effect of spaceflight reducing BV/TV, increasing DA, and reducing Tb.N. Data shown are the mean ± standard deviation with a scatter plot (ns: non-significant). …”
-
33
-
34
-
35
-
36
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
37
General characteristics and clinical data of the subjects included in the study.
Published 2025Subjects: -
38
-
39
-
40